Institutional Fund
Foresite Capital Management Vi LLC
West Hollywood, CACIK 20133415 filings on record
Portfolio Value
$460.27M
Q1 2026
Holdings
17
Reported positions
New Buys
8
Opened this quarter
QoQ Change
+39.1%
from $330.84M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Cg Oncology Inc32.7%
- Alumis Inc20.3%
- Centessa Pharmaceuticals PLC11.8%
- Corvus Pharmaceuticals Inc5.8%
- Denali Therapeutics Inc5.0%
- Agios Pharmaceuticals Inc3.9%
- Other20.5%
Portfolio Holdings
17 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Cg Oncology Inc | 2.22M | $150.35M | 32.7% | 0 | Held |
| 2 | Alumis Inc | 4.25M | $93.58M | 20.3% | 0 | Held |
| 3 | Centessa Pharmaceuticals PLC | 1.36M | $54.18M | 11.8% | 0 | Held |
| 4 | Corvus Pharmaceuticals Inc | 1.83M | $26.79M | 5.8% | +450.0K | Added |
| 5 | Denali Therapeutics Inc | 1.21M | $23.23M | 5.0% | +210.0K | Added |
| 6 | Agios Pharmaceuticals Inc | 525.0K | $17.76M | 3.9% | −5.0K | Reduced |
| 7 | Verastem Inc | 3.15M | $16.68M | 3.6% | +11.5K | Added |
| 8 | Kymera Therapeutics Inc | 146.3K | $12.19M | 2.6% | 0 | Held |
| 9 | Minerva Neurosciences Inc | 1.99M | $11.97M | 2.6% | +1.99M | New |
| 10 | Celldex Therapeutics Inc New | 315.9K | $10.02M | 2.2% | +315.9K | New |
7 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio